Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: Drug Supply Chain Security Act | Statement: [United States federal drug laws, includes, Drug Supply Chain Security Act]

Target entity: Drug Supply Chain Security Act
Context triple: [United States federal drug laws, includes, Drug Supply Chain Security Act]

• A. Prescription Drug Marketing Act
  The Prescription Drug Marketing Act is a U.S. federal law that regulates the distribution and marketing of prescription drugs to ensure their safety, effectiveness, and integrity within the pharmaceutical supply chain.
• B. Food and Drug Administration Amendments Act of 2007
  The Food and Drug Administration Amendments Act of 2007 is a U.S. law that expanded the FDA’s authority over drug and device safety, clinical trials, and post-market surveillance, while enhancing transparency and user fee programs.
• C. Food and Drug Administration Safety and Innovation Act of 2012
  The Food and Drug Administration Safety and Innovation Act of 2012 is a U.S. federal law that reauthorized and expanded FDA user fee programs while enhancing the agency’s authority over drug and medical device safety, innovation, and supply chain oversight.
• D. Prescription Drug User Fee Act of 1992
  The Prescription Drug User Fee Act of 1992 is a U.S. law that authorizes the FDA to collect fees from pharmaceutical companies to fund and expedite the review of new drug applications.
• E. Controlled Substances Import and Export Act
  The Controlled Substances Import and Export Act is a U.S. federal law that regulates and restricts the international import and export of controlled drugs and chemicals to combat drug trafficking and abuse.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: Drug Supply Chain Security Act
Triple: [United States federal drug laws, includes, Drug Supply Chain Security Act]

The Drug Supply Chain Security Act is a U.S. law that establishes a national system to track and verify prescription drugs throughout the supply chain to prevent counterfeit, stolen, or contaminated medicines from reaching patients.

Target entity: Drug Supply Chain Security Act
Target entity description: The Drug Supply Chain Security Act is a U.S. law that establishes a national system to track and verify prescription drugs throughout the supply chain to prevent counterfeit, stolen, or contaminated medicines from reaching patients.

• A. Prescription Drug Marketing Act
  The Prescription Drug Marketing Act is a U.S. federal law that regulates the distribution and marketing of prescription drugs to ensure their safety, effectiveness, and integrity within the pharmaceutical supply chain.
• B. Food and Drug Administration Amendments Act of 2007
  The Food and Drug Administration Amendments Act of 2007 is a U.S. law that expanded the FDA’s authority over drug and device safety, clinical trials, and post-market surveillance, while enhancing transparency and user fee programs.
• C. Food and Drug Administration Safety and Innovation Act of 2012
  The Food and Drug Administration Safety and Innovation Act of 2012 is a U.S. federal law that reauthorized and expanded FDA user fee programs while enhancing the agency’s authority over drug and medical device safety, innovation, and supply chain oversight.
• D. Prescription Drug User Fee Act of 1992
  The Prescription Drug User Fee Act of 1992 is a U.S. law that authorizes the FDA to collect fees from pharmaceutical companies to fund and expedite the review of new drug applications.
• E. Controlled Substances Import and Export Act
  The Controlled Substances Import and Export Act is a U.S. federal law that regulates and restricts the international import and export of controlled drugs and chemicals to combat drug trafficking and abuse.
• F. None of above. chosen